Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antimicrobial hand sanitizers target use by food handlers questioned by FDA.

This article was originally published in The Tan Sheet

Executive Summary

ANTIMICROBIAL HAND SANITIZERS POSITION IN CONTINUUM MODEL CHALLENGED by FDA Anti-infective Drugs Division microbiologist David Bostwick during the first in a series of technical "feedback meetings" on antimicrobial food handler products held by the Center for Drug Evaluation & Research OTC Drugs Division in Rockville, Md. During the general session of the July 21 meeting, Bostwick questioned the inclusion of waterless hand sanitizers in the proposed Healthcare Continuum Model given the products' broad target use, which ranges from home food preparation to use by slaughterhouse workers. Other food handler antimicrobials provide better protection against organisms, Bostwick noted, asking "what is the rationale" for the inclusion of waterless hand sanitizers if the HCCM "already covers [them] in...other types of products."

You may also be interested in...



Antimicrobials

FDA meeting with CTFA to discuss testing of topical antimicrobials will be held Nov. 3 at 2 p.m. in Rockville, Md. The last industry/FDA meeting on the subject took place July 21, 1998, during which FDA officials questioned industry's request to include consumer hand sanitizers in the proposed Healthcare Continuum Model (1"The Tan Sheet" July 27, 1998, p. 16). In August, FDA denied a citizen petition from CHPA and CTFA requesting the agency not take any action on antimicrobial products until the antiseptic monograph is final (2"The Tan Sheet" Aug. 23, p. 10)

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088687

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel